Digital banking startup Mercury closed a $200 million Series D at a $5.2 billion valuation this week—a 49 percent jump from its $3.5 billion valuation just six months prior in March. The round lands amid a measurable fintech funding uptick and suggests investors are rewarding startups that deploy AI as a tool within established business models over those pursuing AI as the product itself. Mercury's valuation surge matters because it challenges the narrative that frontier AI labs command the highest stakes in the funding ecosystem. Instead, the data reveals a more nuanced capital allocation pattern: builders applying machine learning to healthcare, finance, and search infrastructure are attracting deeper checks and steeper valuations.
The trend extends beyond fintech into biotech-adjacent verticals. Gaia, an IVF startup leveraging artificial intelligence trained on millions of anonymized historical fertility outcomes, raised capital by positioning AI as a risk-assessment and probability engine for a $37 billion global fertility market. Meanwhile, Berlin-based Peec, which helps brands track their presence in AI search results, doubled its annualized revenue to $10 million in recent months, demonstrating both the urgency and commercial viability of AI-native vertical software. These three examples—spanning financial services, reproductive medicine, and search infrastructure—share a common denominator: they embed AI into workflows where regulatory approval, clinical validation, or market-proven demand already exist.
The implication is significant for capital allocation trends heading into 2025. If this week's rounds represent a broader pattern, venture money is rotating away from pure foundational model development toward applied startups that operate at the intersection of AI and regulated or capital-intensive industries. The question ahead is sustainability: can these valuations justify themselves if AI commoditizes faster than incumbents adopt it, or will the scarcity of domain expertise and regulatory moats keep valuations elevated? For now, the money is voting decisively for the latter.